TACN - ETF AI Analysis
Top Page
T. Rowe Price Active Core International Equity ETF (TACN)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and over the past few months, indicating positive recent momentum.
Leading Growth-Oriented Holdings
Top positions like ASML and Tokyo Electron have delivered very strong performance, helping drive the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries and sectors, which helps reduce the impact of problems in any single market or industry.
Negative Factors
Small Asset Base
The ETF manages a relatively modest amount of money, which can sometimes mean lower trading volume and wider bid-ask spreads for investors.
Heavy Japan and Europe Exposure
A large share of the portfolio is concentrated in Japan and major European markets, which could hurt returns if those regions struggle.
Mixed Performance Among Top Holdings
Some key positions, such as AstraZeneca, Roche, and Nestlé, have been weak or lagging this year, which can offset gains from stronger stocks.
TACN vs. SPDR S&P 500 ETF (SPY)
AUM21.01M
RegionDeveloped Markets
Expense Ratio0.00%
Beta0.85
IssuerT. Rowe Price
Inception DateN/A
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,129
30 Day Avg. Volume1,957
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.17Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering492
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TACN Summary
The T. Rowe Price Active Core International Equity ETF (TACN) is an actively managed fund that invests in a wide range of companies outside the U.S., mainly in countries like Japan, the UK, and France. It doesn’t track a fixed index, but instead relies on T. Rowe Price’s managers to pick international stocks across many sectors. Well-known holdings include ASML Holding and Nestlé. Someone might invest in TACN to diversify beyond U.S. stocks and seek long-term growth from global markets. A key risk is that international stock prices can be volatile and move up or down with global economic and currency changes.
How much will it cost me?The T. Rowe Price Active Core International Equity ETF (TACN) has an expense ratio of 0.0%, meaning you won’t pay any annual fees for every $1,000 invested. This is significantly lower than average, as most ETFs, especially actively managed ones like TACN, typically charge fees to cover management costs. This makes it an exceptionally cost-effective option for investors.
What would affect this ETF?The T. Rowe Price Active Core International Equity ETF (TACN) could benefit from economic growth in developed markets outside North America, particularly in sectors like financials and industrials, which make up a significant portion of its portfolio. However, it may face challenges from global economic slowdowns, regulatory changes in key regions, or currency fluctuations that could impact international investments. Additionally, sector-specific risks, such as volatility in energy or technology, could influence the ETF's performance.
TACN Top 10 Holdings
TACN’s story is being written largely by its international tech and financial heavyweights. Chip-equipment leaders ASML and Tokyo Electron have been rising sharply, giving the fund a strong tailwind from the global semiconductor boom. Big banks like HSBC and Mitsubishi UFJ are also pulling their weight, helped by firmer rate environments abroad. On the flip side, Sony has been losing steam, acting as a mild drag. Health care names such as AstraZeneca, Roche, and Novartis are more mixed, keeping overall performance steady across developed markets outside North America.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.65% | $766.35K | €633.25B | 151.49% | 76 Outperform | |
| AstraZeneca | 1.68% | $353.12K | $271.40B | 27.54% | 80 Outperform | |
| Tokyo Electron | 1.52% | $318.69K | ¥34.26T | 208.65% | 73 Outperform | |
| HSBC Holdings | 1.38% | $289.26K | £246.00B | 68.71% | 80 Outperform | |
| Roche Holding AG | 1.35% | $282.39K | $315.55B | 23.56% | 73 Outperform | |
| Novartis AG | 1.33% | $279.16K | CHF215.97B | 26.50% | 80 Outperform | |
| Shell (UK) | 1.21% | $254.48K | £166.17B | 12.09% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 1.11% | $233.73K | ¥36.65T | 61.89% | 76 Outperform | |
| Nestlé SA | 1.02% | $213.13K | CHF202.64B | -1.44% | 71 Outperform | |
| BHP Group Ltd | 0.96% | $201.66K | AU$311.95B | 75.44% | 68 Neutral |
TACN Technical Analysis
Positive
―
Price Trends
27.77
Positive
27.36
Positive
Market Momentum
0.16
Negative
58.32
Neutral
68.08
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TACN, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.10, equal to the 50-day MA of 27.77, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.16 indicates Negative momentum. The RSI at 58.32 is Neutral, neither overbought nor oversold. The STOCH value of 68.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TACN.
TACN Peer Comparison
Comparison Results
Performance Comparison
TACN
T. Rowe Price Active Core International Equity ETF
28.54
3.24
12.81%
QUIZ
Zacks Quality International ETF
―
―
―
AIVI
WisdomTree International AI Enhanced Value Fund
―
―
―
JIDE
JPMorgan International Dynamic ETF
―
―
―
PQNT
Pictet AI Enhanced International Equity ETF
―
―
―
IVSI
Applied Finance IVS International Large ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents